Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susan Shapiro

Showing results (51-60 of 60) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 60 results.
Haemophilia : the Official Journal of the World Federation of Hemophilia|February 22, 2023
Emicizumab prophylaxis in haemophilia A with inhibitors: Three years follow-up from the UK Haemophilia Centre Doctors' Organisation (UKHCDO)Caroline Wall, Hua Xiang, Ben Palmer, et al.
Ejhaem|December 15, 2021
Incidence of symptomatic image-confirmed venous thromboembolism in outpatients managed in a hospital-led COVID-19 virtual wardSusan Shapiro, Karim Fouad Alber, Joshua Morton, et al.
The New England Journal of Medicine|July 20, 2022
Phase 1-2 Trial of AAVS3 Gene Therapy in Patients with Hemophilia BPratima Chowdary, Susan Shapiro, Mike Makris, et al.
Critical Care (London, England)|September 19, 2020
Thrombotic and haemorrhagic complications in critically ill patients with COVID-19: a multicentre observational studyAkshay Shah, Killian Donovan, Anna McHugh, et al.
Research and Practice in Thrombosis and Haemostasis|August 21, 2023
Platelet factor XIII-A regulates platelet function and promotes clot retraction and stabilityJoanne L Mitchell, Gemma Little, Alexander P Bye, et al.
Blood Advances|May 9, 2022
The bleeding phenotype in people with nonsevere hemophiliaFabienne R Kloosterman, Anne-Fleur Zwagemaker, Catherine N Bagot, et al.
Journal of Thrombosis and Haemostasis : JTH|January 25, 2023
Little discrepancy between one-stage and chromogenic factor VIII (FVIII)/IX assays in a large international cohort of persons with nonsevere hemophilia A and BAnne-Fleur Zwagemaker, Fabienne R Kloosterman, Samantha C Gouw, et al.
Journal of Thrombosis and Haemostasis : JTH|April 13, 2024
Three-year outcomes of valoctocogene roxaparvovec gene therapy for hemophilia ABella Madan, Margareth C Ozelo, Priyanka Raheja, et al.
The New England Journal of Medicine|February 22, 2023
Two-Year Outcomes of Valoctocogene Roxaparvovec Therapy for Hemophilia AJohnny Mahlangu, Radoslaw Kaczmarek, Annette von Drygalski, et al.
Research and Practice in Thrombosis and Haemostasis|July 11, 2022
Illustrated State-of-the-Art Capsules of the ISTH 2022 CongressRobert A Ariëns, Beverley J Hunt, Ejaife O Agbani, et al.
Pageof 6

Showing results (51-60 of 60) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 60 results.
Haemophilia : the Official Journal of the World Federation of Hemophilia|February 22, 2023
Emicizumab prophylaxis in haemophilia A with inhibitors: Three years follow-up from the UK Haemophilia Centre Doctors' Organisation (UKHCDO)Caroline Wall, Hua Xiang, Ben Palmer, et al.
Ejhaem|December 15, 2021
Incidence of symptomatic image-confirmed venous thromboembolism in outpatients managed in a hospital-led COVID-19 virtual wardSusan Shapiro, Karim Fouad Alber, Joshua Morton, et al.
The New England Journal of Medicine|July 20, 2022
Phase 1-2 Trial of AAVS3 Gene Therapy in Patients with Hemophilia BPratima Chowdary, Susan Shapiro, Mike Makris, et al.
Critical Care (London, England)|September 19, 2020
Thrombotic and haemorrhagic complications in critically ill patients with COVID-19: a multicentre observational studyAkshay Shah, Killian Donovan, Anna McHugh, et al.
Research and Practice in Thrombosis and Haemostasis|August 21, 2023
Platelet factor XIII-A regulates platelet function and promotes clot retraction and stabilityJoanne L Mitchell, Gemma Little, Alexander P Bye, et al.
Blood Advances|May 9, 2022
The bleeding phenotype in people with nonsevere hemophiliaFabienne R Kloosterman, Anne-Fleur Zwagemaker, Catherine N Bagot, et al.
Journal of Thrombosis and Haemostasis : JTH|January 25, 2023
Little discrepancy between one-stage and chromogenic factor VIII (FVIII)/IX assays in a large international cohort of persons with nonsevere hemophilia A and BAnne-Fleur Zwagemaker, Fabienne R Kloosterman, Samantha C Gouw, et al.
Journal of Thrombosis and Haemostasis : JTH|April 13, 2024
Three-year outcomes of valoctocogene roxaparvovec gene therapy for hemophilia ABella Madan, Margareth C Ozelo, Priyanka Raheja, et al.
The New England Journal of Medicine|February 22, 2023
Two-Year Outcomes of Valoctocogene Roxaparvovec Therapy for Hemophilia AJohnny Mahlangu, Radoslaw Kaczmarek, Annette von Drygalski, et al.
Research and Practice in Thrombosis and Haemostasis|July 11, 2022
Illustrated State-of-the-Art Capsules of the ISTH 2022 CongressRobert A Ariëns, Beverley J Hunt, Ejaife O Agbani, et al.
Pageof 6